FDA Approves Unknown Drug — NATCO PHARMA

NATCO Pharma announced Friday that the FDA approved its ANDA submission, potentially opening a new revenue stream through the branded competitor's generic release. This regulatory clearance positions the company to capitalize on market demand following the loss of exclusivity for the reference product.